- Home
- SANW vs NDRA Comparison
SANW vs NDRA Comparison
Compare SANW & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- NDRA
- Stock Information
- Founded
- SANW 1980
- NDRA 2007
- Country
- SANW United States
- NDRA United States
- Employees
- SANW N/A
- NDRA N/A
- Industry
- SANW Farming/Seeds/Milling
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SANW Consumer Staples
- NDRA Health Care
- Exchange
- SANW Nasdaq
- NDRA Nasdaq
- Market Cap
- SANW 5.2M
- NDRA 5.1M
- IPO Year
- SANW 2010
- NDRA 2017
- Fundamental
- Price
- SANW $2.23
- NDRA $4.54
- Analyst Decision
- SANW
- NDRA Strong Buy
- Analyst Count
- SANW 0
- NDRA 1
- Target Price
- SANW N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- SANW 20.0K
- NDRA 709.8K
- Earning Date
- SANW 11-19-2024
- NDRA 11-15-2024
- Dividend Yield
- SANW N/A
- NDRA N/A
- EPS Growth
- SANW N/A
- NDRA N/A
- EPS
- SANW N/A
- NDRA N/A
- Revenue
- SANW $60,441,646.00
- NDRA N/A
- Revenue This Year
- SANW $9.69
- NDRA N/A
- Revenue Next Year
- SANW $53.85
- NDRA N/A
- P/E Ratio
- SANW N/A
- NDRA N/A
- Revenue Growth
- SANW N/A
- NDRA N/A
- 52 Week Low
- SANW $2.10
- NDRA $4.41
- 52 Week High
- SANW $14.25
- NDRA $4,882.50
- Technical
- Relative Strength Index (RSI)
- SANW 34.39
- NDRA 31.46
- Support Level
- SANW $2.10
- NDRA $5.23
- Resistance Level
- SANW $2.32
- NDRA $8.80
- Average True Range (ATR)
- SANW 0.22
- NDRA 1.58
- MACD
- SANW 0.05
- NDRA -0.06
- Stochastic Oscillator
- SANW 17.81
- NDRA 1.73
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. It produces approximately 500 650 seed products and has a sale in more than 40 30 countries. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.